Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-26

FDA Approved: ATOMOXETINE — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for atomoxetine by Dr. Reddy's Laboratories Limited, resulting in a new generic entry for ADHD treatment in the U.S. mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

SUPPL AP for ATOMOXETINE (ATOMOXETINE)